SCHEMBL24311746

SCHEMBL24311746

O=C1CC2CCCCCCC2N1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.36
ALDH1A1 P00352 2/20 0.36
PKM P14618 1/20 0.36
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
OPRM1 P35372 3/20 0.33
OPRL1 P41146 3/20 0.33
SMYD3 Q9H7B4 1/20 0.33
MAP3K14 Q99558 1/20 0.33
OPRK1 P41145 2/20 0.33
PARP1 P09874 1/20 0.31
ITGB3 P05106 1/20 0.30
ITGB2 P05107 1/20 0.30
ITGB1 P05556 1/20 0.30
ITGAV P06756 1/20 0.30
ITGA2B P08514 1/20 0.30
ITGA5 P08648 1/20 0.30
ITGB5 P18084 1/20 0.30
ITGAL P20701 1/20 0.30
OPRD1 P41143 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19671609 1.00 MAPT (0.36) MAPTALDH1A1PKMLMNATSHR
SCHEMBL17974614 1.00 MAPT (0.36) MAPTALDH1A1PKMLMNATSHR
SCHEMBL5560865 0.98 ALDH1A1 (0.37) MAPTALDH1A1PKMLMNATSHR
SCHEMBL6685775 0.98 ALDH1A1 (0.37) MAPTALDH1A1PKMLMNATSHR
SCHEMBL8450841 0.98 ALDH1A1 (0.37) MAPTALDH1A1PKMLMNATSHR
SCHEMBL5560867 0.98 ALDH1A1 (0.37) MAPTALDH1A1PKMLMNATSHR
SCHEMBL785503 0.98 ALDH1A1 (0.37) MAPTALDH1A1PKMLMNATSHR
SCHEMBL10758827 0.98 ALDH1A1 (0.37) MAPTALDH1A1PKMLMNATSHR
SCHEMBL22556208 0.93
SCHEMBL3738614 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220106324-A1 DISPIROPYRROLIDINE DERIVATIVES DAIICHI SANKYO COMPANY, LIMITED (JP) 2022-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220106324-A1 DISPIROPYRROLIDINE DERIVATIVES MDM2, TP53, TP53BP1 MAPT 4318/4885ALDH1A1 1254/4885PKM 4006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.